Skip to menu Skip to content Skip to footer

2026

Journal Article

SMART: preliminary efficacy, feasibility and acceptability of a theory-informed digital intervention for metabolic health in people with schizophrenia and related disorders

Arnautovska, Urska, Ritchie, Gabrielle, Korman, Nicole, Menon, Anish, Milton, Alyssa, Varnfield, Marlien, Kelly, Jaimon, Jansen, Pieter, Baker, Andrea, Kisely, Steve, Russell, Anthony, Siskind, Dan and Trott, Mike (2026). SMART: preliminary efficacy, feasibility and acceptability of a theory-informed digital intervention for metabolic health in people with schizophrenia and related disorders. BJPsych Open, 12 (3) e122, e122. doi: 10.1192/bjo.2026.11032

SMART: preliminary efficacy, feasibility and acceptability of a theory-informed digital intervention for metabolic health in people with schizophrenia and related disorders

2026

Journal Article

Initial physical health assessment for psychosis in Australia and New Zealand: 2026 recommendations

Warren, Nicola, O'Gorman, Cullen, Dark, Frances, Halstead, Sean, Every-Palmer, Susanna, Korman, Nicole, Lappin, Julia, Lawn, Sharon, O'Donoghue, Brian, Suetani, Shuichi, Thompson, Andrew, Loi, Samantha M., Scott, James G., Runnegar, Naomi, Pillinger, Toby, McCutcheon, Robert A., Blackman, Graham, Skerlj, Thomas, Firman, Jessemin and Siskind, Dan (2026). Initial physical health assessment for psychosis in Australia and New Zealand: 2026 recommendations. Australian and New Zealand Journal of Psychiatry 00048674261435740. doi: 10.1177/00048674261435740

Initial physical health assessment for psychosis in Australia and New Zealand: 2026 recommendations

2026

Journal Article

Multidisciplinary consensus on prevention, screening and monitoring of clozapine-associated myocarditis and clozapine rechallenge after myocarditis

Wagner, Elias, Korman, Nicole, Solmi, Marco, Mortazavi, Matin, Aminifarsani, Zahra, Dubrovin Leão, Douglas, Burrage, Matthew K., Siskind, Dan, McMahon, Laura, Howes, Oliver D., Correll, Christoph U., CAM Expert Group and Hasan, Alkomiet (2026). Multidisciplinary consensus on prevention, screening and monitoring of clozapine-associated myocarditis and clozapine rechallenge after myocarditis. British Journal of Psychiatry, 228 (4), 348-356. doi: 10.1192/bjp.2025.89

Multidisciplinary consensus on prevention, screening and monitoring of clozapine-associated myocarditis and clozapine rechallenge after myocarditis

2026

Journal Article

Scoping review of co-design in mental health research: essential elements and recommendations

Roennfeldt, Helena, Stewart, Victoria, Wyder, Marianne, Fawcett, Teresa, Robertson, Caroline, Soole, Rebecca, Siskind, Dan, Wheeler, Amanda and Chapman, Justin (2026). Scoping review of co-design in mental health research: essential elements and recommendations. OTJR-Occupational Therapy Journal of Research, 46 (2) 15394492251367259, 311-323. doi: 10.1177/15394492251367259

Scoping review of co-design in mental health research: essential elements and recommendations

2026

Journal Article

Multidisciplinary consensus on prevention, screening and monitoring of clozapine-associated myocarditis and clozapine rechallenge after myocarditis – ADDENDUM

Wagner, Elias, Korman, Nicole, Solmi, Marco, Mortazavi, Matin, Aminifarsani, Zahra, Dubrovin Leão, Douglas, Burrage, Matthew K., Siskind, Dan, McMahon, Laura, Howes, Oliver D., Correll, Christoph U., CAM Expert Group and Hasan, Alkomiet (2026). Multidisciplinary consensus on prevention, screening and monitoring of clozapine-associated myocarditis and clozapine rechallenge after myocarditis – ADDENDUM. The British Journal of Psychiatry, 228 (4), 387-387. doi: 10.1192/bjp.2025.10372

Multidisciplinary consensus on prevention, screening and monitoring of clozapine-associated myocarditis and clozapine rechallenge after myocarditis – ADDENDUM

2026

Other Outputs

Cochrane publications

Plever, Sally, Kisely, Steve, Bonevski, Billie, Siskind, Dan, Guillaumier, Ashleigh, Thaker, Parth, Yamazaki-Tan, Julia, Vos, Greta, Kim, Doyoon and Gartner, Coral (2026). Cochrane publications. The University of Queensland. (Dataset) doi: 10.48610/7043ee2

Cochrane publications

2026

Journal Article

Comparative incidence rates of physical multimorbidity in a psychiatric inpatient population among people with and without severe mental illness: A retrospective cohort study

Halstead, Sean, Arnautovska, Urska, Kisely, Steve, Siskind, Dan and Warren, Nicola (2026). Comparative incidence rates of physical multimorbidity in a psychiatric inpatient population among people with and without severe mental illness: A retrospective cohort study. Australian & New Zealand Journal of Psychiatry 00048674261426908, 48674261426908. doi: 10.1177/00048674261426908

Comparative incidence rates of physical multimorbidity in a psychiatric inpatient population among people with and without severe mental illness: A retrospective cohort study

2026

Journal Article

Immediate Psychological Responses to Aerobic and Resistance Exercise in People With Psychotic Disorders: A Randomized Controlled Trial in Psychiatric Rehabilitation

Korman, Nicole, Chapman, Justin, Romain, Ahmed Jerome, Arnautovska, Urska, Stubbs, Brendon, Rosenbaum, Simon, Siskind, Dan J, Stanton, Robert and Trott, Mike (2026). Immediate Psychological Responses to Aerobic and Resistance Exercise in People With Psychotic Disorders: A Randomized Controlled Trial in Psychiatric Rehabilitation. Schizophrenia Bulletin, 52 (2) sbag012, 2. doi: 10.1093/schbul/sbag012

Immediate Psychological Responses to Aerobic and Resistance Exercise in People With Psychotic Disorders: A Randomized Controlled Trial in Psychiatric Rehabilitation

2026

Journal Article

Physical activity and exercise ‘snacks’: a small step towards big gains in severe mental illness

Trott, Mike, Arnautovska, Urska, Siskind, Dan, Firth, Joseph, Stubbs, Brendon, Smith, Lee, Chapman, Justin and Korman, Nicole (2026). Physical activity and exercise ‘snacks’: a small step towards big gains in severe mental illness. British Journal of Sports Medicine, 60 (9) bjsports-2025-111181, bjsports-2025. doi: 10.1136/bjsports-2025-111181

Physical activity and exercise ‘snacks’: a small step towards big gains in severe mental illness

2026

Journal Article

An international adult guideline for making Clozapine titration safer by using six ancestry-based personalized dosing titrations, CRP, and Clozapine levels 基于种族、CRP和血药浓度进行氯氮平成人个体化剂量滴定降低不良反应国际指南(全译)

de Leon, Jose, Schoretsanitis, Georgios, Smith, Robert L., Molden, Espen, Solismaa, Anssi, Seppälä, Niko, Kopeček, Miloslav, Švancer, Patrik, Olmos, Ismael, Ricciardi, Carina, Iglesias-Garcia, Celso, Iglesias-Alonso, Ana, Spina, Edoardo, Ruan, Can-Jun, Wang, Chuan-Yue, Wang, Gang, Tang, Yi-Lang, Lin, Shih-Ku, Lane, Hsien-Yuan, Kim, Yong Sik, Kim, Se Hyun, Rajkumar, Anto P., González-Esquivel, Dinora F., Jung-Cook, Helgi, Baptista, Trino, Rohde, Christopher, Nielsen, Jimmi, Verdoux, Hélène, Quiles, Clelia ... Müller, Daniel J. (2026). An international adult guideline for making Clozapine titration safer by using six ancestry-based personalized dosing titrations, CRP, and Clozapine levels 基于种族、CRP和血药浓度进行氯氮平成人个体化剂量滴定降低不良反应国际指南(全译). Chinese Journal of Psychiatry, 59 (2), 87-113. doi: 10.3760/cma.j.cn113661-20250402-00157

An international adult guideline for making Clozapine titration safer by using six ancestry-based personalized dosing titrations, CRP, and Clozapine levels 基于种族、CRP和血药浓度进行氯氮平成人个体化剂量滴定降低不良反应国际指南(全译)

2026

Journal Article

Barriers and facilitators of smoking cessation among people receiving treatment for mental health disorders: perspectives of healthcare providers

Puljević, Cheneal, Holland, Alice, Gartner, Coral, Roennfeldt, Helena, Elvidge, Norah, Siskind, Dan and Wyder, Marianne (2026). Barriers and facilitators of smoking cessation among people receiving treatment for mental health disorders: perspectives of healthcare providers. Community Mental Health Journal, 62 (2), 325-334. doi: 10.1007/s10597-025-01526-0

Barriers and facilitators of smoking cessation among people receiving treatment for mental health disorders: perspectives of healthcare providers

2026

Journal Article

New guidelines for management of schizophrenia in Australia and Aotearoa New Zealand

Suetani, Shuichi, Galletly, Cherrie, Lawn, Sharon and Siskind, Dan (2026). New guidelines for management of schizophrenia in Australia and Aotearoa New Zealand. Australian & New Zealand Journal of Psychiatry, 60 (4) 00048674261418446, 305-307. doi: 10.1177/00048674261418446

New guidelines for management of schizophrenia in Australia and Aotearoa New Zealand

2026

Journal Article

Smoking, plasma concentration, antipsychotic polypharmacy and adverse drug reaction burden in clozapine outpatients

Tanzer, Timothy, Rutland, Emilie, Warren, Nicola, Barras, Michael, Kisely, Steve and Siskind, Dan (2026). Smoking, plasma concentration, antipsychotic polypharmacy and adverse drug reaction burden in clozapine outpatients. Australian and New Zealand Journal of Psychiatry, 60 (5) 00048674251412103, 48674251412103-505. doi: 10.1177/00048674251412103

Smoking, plasma concentration, antipsychotic polypharmacy and adverse drug reaction burden in clozapine outpatients

2026

Journal Article

Australian and New Zealand Journal of Psychiatry Grading of Recommendations, Assessment, Development and Evaluations (GRADE) guidelines for the management of schizophrenia

Suetani, Shuichi, Dark, Frances, Every-Palmer, Susanna, Galletly, Cherrie, O’Donoghue, Brian, Halstead, Sean C., Keating, Dolores, Korman, Nicole, Lappin, Julia, Lawn, Sharon, Thompson, Andrew, Warren, Nicola and Siskind, Dan (2026). Australian and New Zealand Journal of Psychiatry Grading of Recommendations, Assessment, Development and Evaluations (GRADE) guidelines for the management of schizophrenia. Australian and New Zealand Journal of Psychiatry, 60 (4) 00048674251406058, 48674251406058-404. doi: 10.1177/00048674251406058

Australian and New Zealand Journal of Psychiatry Grading of Recommendations, Assessment, Development and Evaluations (GRADE) guidelines for the management of schizophrenia

2026

Conference Publication

REAL-WORLD EFFECTIVENESS OF CLOZAPINE AUGMENTATION WITH MOOD STABILIZERS: EVIDENCE FROM TWO NATIONWIDE COHORTS

Solismaa, Anssi, Taipale, Heidi, Siskind, Dan, Tanskanen, Antti, Mittendorfer-Rutz, Ellenor, Correll, Christoph and Tiihonen, Jari (2026). REAL-WORLD EFFECTIVENESS OF CLOZAPINE AUGMENTATION WITH MOOD STABILIZERS: EVIDENCE FROM TWO NATIONWIDE COHORTS. 64th Annual Meeting of the American-College-of-Neuropsychopharmacology (ACNP), nassau Bahamas, Jan 12-15, 2026. LONDON: SPRINGERNATURE.

REAL-WORLD EFFECTIVENESS OF CLOZAPINE AUGMENTATION WITH MOOD STABILIZERS: EVIDENCE FROM TWO NATIONWIDE COHORTS

2026

Journal Article

Exploring user perspectives on SMART: qualitative study of novel digital intervention targeting metabolic care in schizophrenia and related disorders

Arnautovska, Urska, Ritchie, Gabrielle, Soole, Rebecca, Baker, Andrea, Korman, Nicole, Bialkowski, Agata, Siskind, Dan and Milton, Alyssa (2026). Exploring user perspectives on SMART: qualitative study of novel digital intervention targeting metabolic care in schizophrenia and related disorders. BJPsych Open, 12 (1) e44, e44. doi: 10.1192/bjo.2025.10954

Exploring user perspectives on SMART: qualitative study of novel digital intervention targeting metabolic care in schizophrenia and related disorders

2026

Journal Article

Interventions to prevent antipsychotic-induced weight gain and metabolic complications in individuals with a first-episode psychosis and minimal antipsychotic exposure: a systematic review and meta-analysis

O’Mahony, Brian William, Burke, Tara, Hamill, Ruby, Gannon, Louisa, Perry, Benjamin I., Siskind, Dan, Pawełczyk, Tomasz, O’Shea, Donal and O’Donoghue, Brian (2026). Interventions to prevent antipsychotic-induced weight gain and metabolic complications in individuals with a first-episode psychosis and minimal antipsychotic exposure: a systematic review and meta-analysis. Psychological Medicine, 56 e101. doi: 10.1017/s0033291726104139

Interventions to prevent antipsychotic-induced weight gain and metabolic complications in individuals with a first-episode psychosis and minimal antipsychotic exposure: a systematic review and meta-analysis

2026

Journal Article

Absolute neutrophil count and adverse drug reaction monitoring during clozapine treatment: consensus guidelines from a global Delphi panel

Siskind, Dan, Northwood, Korinne, Pillinger, Toby, Chan, Sherry, Correll, Christoph, Cotes, Robert O., Every-Palmer, Susanna, Hahn, Maggie, Howes, Oliver D., Kane, John M., Kelly, Deanna, Korman, Nicole, Lappin, Julia, Mena, Cristián, Myles, Nick, McCutcheon, Robert A., Siskind, Dan, McCutcheon, Robert A., Northwood, Korinne, Pillinger, Toby, Chan, Sherry, Correll, Christoph U., Cotes, Robert, Every-Palmer, Susanna, Hahn, Margaret, Howes, Oliver, Kane, John M., Kelly, Deanna L., Korman, Nicole ... Yung, Alison (2026). Absolute neutrophil count and adverse drug reaction monitoring during clozapine treatment: consensus guidelines from a global Delphi panel. The Lancet Psychiatry, 13 (1), 77-86. doi: 10.1016/s2215-0366(25)00098-7

Absolute neutrophil count and adverse drug reaction monitoring during clozapine treatment: consensus guidelines from a global Delphi panel

2026

Journal Article

Impact of long-acting injectable versus oral antipsychotic treatment on all-cause discontinuation risk in people with early phase schizophrenia and comorbid substance use disorder: A secondary analysis of the EULAST randomized trial

Mortazavi, Matin, Aminifarsani, Zahra, Rossum, Inge Winter-van, Kahn, Rene S., Fleischhacker, W. Wolfgang, Davidson, Michael, Weiser, Mark, Siskind, Dan (EULAST Study Group), Leucht, Stefan, Hasa, Alkomiet, Wagner, Elias and EULAST Study Group (2026). Impact of long-acting injectable versus oral antipsychotic treatment on all-cause discontinuation risk in people with early phase schizophrenia and comorbid substance use disorder: A secondary analysis of the EULAST randomized trial. CNS Drugs, 40 (1), 99-109. doi: 10.1007/s40263-025-01225-0

Impact of long-acting injectable versus oral antipsychotic treatment on all-cause discontinuation risk in people with early phase schizophrenia and comorbid substance use disorder: A secondary analysis of the EULAST randomized trial

2026

Journal Article

Clinical criteria to guide anti-neuronal antibody testing for people with early and persistent psychosis attending mental health services

McKeon, Gemma, Baker, Andrea, Blum, Stefan, Gillis, David, Prain, Kerri, Greer, Judith M., Bruxner, George, Benros, Michael E., Hatherill, Sean, Suetani, Shuichi, Siskind, Dan, Murphy, Kate, Joshi, Hitesh, Curtis, Jackie, O’Donoghue, Brian, Macmillan, Iain, Malacova, Eva, Pelecanos, Anita, Waters, Patrick, Lennox, Belinda, Warren, Nicola and Scott, James G. (2026). Clinical criteria to guide anti-neuronal antibody testing for people with early and persistent psychosis attending mental health services. Biological Psychiatry Global Open Science, 6 (1) 100612, 1-13. doi: 10.1016/j.bpsgos.2025.100612

Clinical criteria to guide anti-neuronal antibody testing for people with early and persistent psychosis attending mental health services